… initial cohort of six end-stage renal disease (ESRD) patients, expanding to … associated with conventional drug approvals. Participants will … a therapeutic treatment option to ESRD patients; and … must use immunosuppressive medications to prevent rejection of …

… m2 (the latter – end-stage renal disease, ESRD). No information was available … diagnosis and/or treatment. Similarly, other chronic … between cardiovascular disease, cardiovascular drug therapy, and in-hospital … filtration rate. Ann Intern Med. 2006;145(4): …

… are not treatable with drugs. The Company’s lead … with regularly schedule dialysis treatments to address endotoxemia and … shorten the lives of end-stage renal disease (ESRD) patients. Extending the … lives of individuals with ESRD could significantly impact …

… : AFP The US Food and Drug Administration approved clinical trials that … initially include six people with end-stage renal disease in the study, eventually enrolling …

… Medicare for reasons besides end-stage renal disease. We included discharges … respectively). During baseline, treatment and control hospitals had … adherence to treatment: a meta-analysis. Med Care. 2009 … Economic impact of medication non-adherence by disease …

The Food and Drug Administration has given two biotechnology … start with six patients with end-stage renal disease around the middle of this …

… Insurance to support patients with end-stage renal disease, sickle cell disease, and … Institute for Cancer Research and Treatment (NICRAT), outlined significant strides … encourage prevention, early detection, and treatment. The “United by Unique” campaign …

… tested positive for the banned drug Roxadustat. Roxadustat was approved for … symptoms of anemia caused by chronic kidney failure. It stimulates the body to …

… product behind the cancer drug Keytruda, but “macroeconomic factors … dose six patients with end-stage renal disease, and once those patients … launched a taxpayer-funded drug development program at … almost exclusively focused on drugs owned by private industry, …

… end-stage renal disease (ESRD) via xenotransplant, has received clearance of an investigational new drug … for many patients with ESRD,” Noah Byrd, PhD, … hundreds of thousands of ESRD patients.” According to … of its investigational new drug application for the …